We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.88B
AUM Growth
+$2.33M
Cap. Flow
-$53.6M
Cap. Flow %
-1.86%
Top 10 Hldgs %
54.74%
Holding
161
New
15
Increased
43
Reduced
42
Closed
18

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$64.7M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$53.8M
3
RH icon
RH
RH
+$51.1M
4
PDD icon
Pinduoduo
PDD
+$49.4M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$28.6M

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$73.7M
2
SU icon
Suncor Energy
SU
+$59.1M
3
MU icon
Micron Technology
MU
+$52.7M
4
LGIH icon
LGI Homes
LGIH
+$32.4M
5
HTHT icon
Huazhu Hotels Group
HTHT
+$25.4M

Sector Composition

Rank Sector Weight
1 Technology 18.16%
2 Industrials 16.21%
3 Consumer Discretionary 15.33%
4 Healthcare 13.64%
5 Financials 13.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMVT icon
51
Immunovant
IMVT
$8.25B
$6.24M 0.22%
328,842
-18,128
-5% -$338K
MASS icon
52
908 Devices
MASS
$364M
$6.01M 0.21%
875,447
– –
INBX
53
DELISTED
Inhibrx, Inc. Common Stock
INBX
$5.95M 0.21%
229,036
+6,827
+3% +$159K
COGT icon
54
Cogent Biosciences
COGT
$7.24B
$5.65M 0.2%
477,080
– –
OMGA
55
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$4.97M 0.17%
888,335
-34,956
-4% -$273K
ESPR
56
DELISTED
Esperion Therapeutics
ESPR
$4.82M 0.17%
3,469,634
+889,059
+34% +$1.24M
RCUS icon
57
Arcus Biosciences
RCUS
$3.64B
$4.72M 0.16%
232,612
– –
MRNA icon
58
Moderna
MRNA
$23.6B
$4.63M 0.16%
38,126
– –
NSTG
59
DELISTED
NanoString Technologies, Inc.
NSTG
$4.52M 0.16%
1,116,392
-113,411
-9% -$837K
MTCH icon
60
Match Group
MTCH
$8.55B
$4.51M 0.16%
107,826
– –
SAGE
61
DELISTED
Sage Therapeutics
SAGE
$4.32M 0.15%
91,933
+16,013
+21% +$797K
MRUS
62
DELISTED
Merus
MRUS
$3.96M 0.14%
150,238
-88,814
-37% -$1.94M
ACIU icon
63
AC Immune
ACIU
$240M
$3.91M 0.14%
1,322,462
+240,000
+22% +$524K
ZLAB icon
64
Zai Lab
ZLAB
$2.62B
$3.74M 0.13%
134,783
– –
CNTG
65
DELISTED
Centogene N.V. Common Shares
CNTG
$3.57M 0.12%
2,377,150
– –
BPMC
66
DELISTED
Blueprint Medicines
BPMC
$3.55M 0.12%
56,171
– –
ZYME icon
67
Zymeworks
ZYME
$1.67B
$3.54M 0.12%
409,839
+3,512
+0.9% +$31.4K
ARWR icon
68
Arrowhead Research
ARWR
$12.4B
$3.47M 0.12%
97,168
+20,960
+28% +$723K
VERA icon
69
Vera Therapeutics
VERA
$2.36B
$3.37M 0.12%
+209,700
New +$1.89M
BIO icon
70
Bio-Rad Laboratories Class A
BIO
$9.42B
$3.27M 0.11%
8,636
-9,706
-53% -$3.95M
IMTX icon
71
Immatics
IMTX
$1.32B
$3.1M 0.11%
268,211
– –
GOSS icon
72
Gossamer Bio
GOSS
$87M
$2.84M 0.1%
2,363,170
– –
PRTA icon
73
Prothena Corp
PRTA
$450M
$2.83M 0.1%
41,508
– –
ALLK
74
DELISTED
Allakos
ALLK
$2.77M 0.1%
635,023
– –
ADPT icon
75
Adaptive Biotechnologies
ADPT
$3.97B
$2.46M 0.09%
366,230
– –
1 2
3
4 5

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Platinum Investment Management held 161 positions worth $2.88B, up 0.08% from $2.88B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Platinum Investment Management's Q2 2023 filing shows 15 new, 43 increased, 42 reduced and 18 closed positions. Its largest new stake was RH: 195,375 shares worth $64.4M. The largest sale was GE Aerospace, an estimated $73.7M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Platinum Investment Management's largest Q2 2023 buy was RH: 195,375 shares worth $64.4M.
  • Platinum Investment Management added most to Baxter International in Q2 2023, an estimated $64.7M increase.
  • Platinum Investment Management's biggest Q2 2023 reduction was Suncor Energy, cutting an estimated $59.1M.
  • Platinum Investment Management fully exited GE Aerospace in Q2 2023, selling an estimated $73.7M.
  • Platinum Investment Management's ten largest holdings make up 55% of its $2.88B portfolio in Q2 2023.
  • Platinum Investment Management opened 15 new positions and closed 18 in Q2 2023.
  • Platinum Investment Management's portfolio value rose 0.08% quarter-over-quarter to $2.88B.

Based on Platinum Investment Management's 13F filing for Q2 2023, filed 11 Aug 2023.